Evidence map›Paper›PMID 31048912›Full record

ArticlePloS one2019

Methods, outcomes, and costs of a 2.5 year comprehensive facility-and community-based HIV testing intervention in Bukoba Municipal Council, Tanzania, 2014-2017.

Haddi Jatou Cham, Duncan MacKellar, Haruka Maruyama, Oscar Ernest Rwabiyago, Omari Msumi, Claire Steiner, Gerald Kundi, Rachel Weber, Johnita Byrd, Chutima Suraratdecha and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 3 countries.

Haddi Jatou ChamDivision of Global HIV and TB, National Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-3133-230X
Duncan MacKellarDivision of Global HIV and TB, National Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Haruka MaruyamaICAP at Columbia University, Dar es Salaam, Tanzania.
Oscar Ernest RwabiyagoU.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Omari MsumiICAP at Columbia University, Dar es Salaam, Tanzania.
Claire SteinerICAP at Columbia University, Dar es Salaam, Tanzania.
Gerald KundiICAP at Columbia University, Dar es Salaam, Tanzania.
Rachel WeberU.S. Centers for Disease Control and Prevention, Yaounde, Cameroon.
Johnita ByrdICF International, Atlanta, Georgia, United States of America.
Chutima SuraratdechaDivision of Global HIV and TB, National Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Tewodaj MengistuDivision of Global HIV and TB, National Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Eliufoo ChuriHenry Jackson Foundation Medical Research International, Mbeya, Tanzania.
Sherri PalsDivision of Global HIV and TB, National Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Caitlin Madevu-MatsonICAP at Columbia University, New York, New York, United States of America.
Geofrey AlexanderTanzania Health Promotion Support, Dar es Salaam, Tanzania.
Sarah PorterDivision of Global HIV and TB, National Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kokuhumbya KazauraU.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Deogratius MbilinyiUnited Nations Children's Fund, Dar es Salaam, Tanzania.
Fernando MoralesICAP at Columbia University, Dar es Salaam, Tanzania.
Thomas RutachunzibwaMinistry of Health, Community Development, Gender, Elderly and Children, Bukoba, Tanzania.
Jessica JustmanTanzania Health Promotion Support, Dar es Salaam, Tanzania.
Anath RwebemberaNational AIDS Control Program, Ministry of Health, Community Development, Gender, Elderly and Children, Dar es Salaam, Tanzania.
Centers for Disease Control and Prevention · USUniversity of Dar es Salaam · TZMinistry of Health, Community Development, Gender, Elderly and Children · TZICAP Global HealthICF International (United States) · USMinistry of Public Health · CMWWF Tanzania · TZ

Funding

PEPFAR
6 · The paper itself

Abstract

To diagnose ≥90% HIV-infected residents (diagnostic coverage), the Bukoba Combination Prevention Evaluation (BCPE) implemented provider-initiated (PITC), home- (HBHTC), and venue-based (VBHTC) HIV testing and counseling (HTC) intervention in Bukoba Municipal Council, a mixed urban and rural lake zone community of 150,000 residents in Tanzania. This paper describes the methods, outcomes, and incremental costs of these HTC interventions. PITC was implemented in outpatient department clinics in all eight public and three faith-based health facilities. In clinics, lay counselors routinely screened and referred eligible patients for HIV testing conducted by HTC-dedicated healthcare workers. In all 14 wards, community teams offered HTC to eligible persons encountered at 31,293 home visits and at 79 male- and youth-frequented venues. HTC was recommended for persons who were not in HIV care or had not tested in the prior 90 days. BCPE conducted 133,695 HIV tests during the 2.5 year intervention (PITC: 88,813, 66%; HBHTC: 27,407, 21%; VBHTC: 17,475, 13%). Compared with other strategies, PITC conducted proportionally more tests among females (65%), and VBHTC conducted proportionally more tests among males (69%) and young-adults aged 15-24 years (42%). Of 5,550 (4.2% of all tests) HIV-positive tests, 4,143 (75%) clients were newly HIV diagnosed, including 1,583 males and 881 young adults aged 15-24 years. Of HIV tests conducted 3.7%, 1.8%, and 2.1% of PITC, HBHTC, and VBHTC clients, respectively, were newly HIV diagnosed; PITC accounted for 79% of all new diagnoses. Cost per test (per new diagnosis) was $4.55 ($123.66), $6.45 ($354.44), and $7.98 ($372.67) for PITC, HBHTC, and VBHTC, respectively. In a task-shifting analysis in which lay counselors replaced healthcare workers, estimated costs per test (per new diagnosis) would have been $3.06 ($83.15), $ 4.81 ($264.04), and $5.45 ($254.52), for PITC, HBHTC, and VBHTC, respectively. BCPE models reached different target groups, including men and young adults, two groups with consistently low coverage. Implementation of multiple models is likely necessary to achieve ≥90% diagnostic coverage.

Indexed as

Costs and Cost AnalysisOutcome Assessment, Health CareResidence CharacteristicsAdolescentAdultCitiesFemaleHIV InfectionsHumansMaleMass ScreeningMiddle AgedTanzaniaYoung Adult

Identifiers

PMID31048912
PMCPMC6497243
OpenAlexW2943248186

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.